GRDN - Company ID 0001802255
The table below shows Guardian Pharmacy Services, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $336.60M | $377.43M | $344.33M | $329.31M | $314.39M | $300.04M |
| Cost of revenue | $260.29M | $302.71M | $276.19M | $264.96M | $253.51M | $238.75M |
| Gross profit | $76.31M | $74.72M | $68.15M | $64.35M | $60.88M | $61.29M |
| R&D | - | - | - | - | - | - |
Guardian Pharmacy Services, Inc. reported annual revenue of $1.45B for fiscal year 2025. That is up 17.9% from $1.23B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $58.63M | $58.37M | $55.57M | $51.34M | $165.49M | $44.28M |
| Operating income | $17.68M | $16.35M | $12.58M | $13.01M | -$104.61M | $17.00M |
| Income tax | $4.75M | $7.04M | $3.76M | $3.83M | $176.00K | $0.00 |
| Net income | $13.29M | $9.82M | $9.03M | $9.45M | -$121.99M | $0.00 |
| EPS (diluted) | - | - | - | - | - | - |